-
![Pharmaceutical Raw Material and Intermedia |Diabetes |3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |CAS No.762240-92-6](https://www.yisunbio.com/uploads/pgy-Ce1.jpg)
Pharmaceutical Raw Material and Intermedia |Diabetes |3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |CAS No.762240-92-6
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Active Pharmaceutical Ingredient Intermedia |Diabetes |3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride|CAS:762240-92-6
-
Pharmaceutical Raw Material and Intermedia |Diabetes |Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)acidi butanoicum |CAS No.486460-00-8
Lorem vestibulum ac copia biopharmaceutical |Raw Materials |Active Pharmaceutical Ingredient Intermedia |Diabetes |Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)acidi butanoicum |CAS:486460-00-8